Indecopi initiates penal proceedings and issues precautionary measures against Medifarma for defective serums

The Technical Secretariat of the Indecopi Consumer Protection Commission No. 3 has initiated an administrative sanctioning procedure against Medifarma, due to the marketing of lot 2123624-1 of the physiological serum, which presents a defect that represents a risk to the health and safety of consumers, which has resulted in fatal victims and affected patients.The Indecopi has also ordered, as precautionary measures, that the laboratory take care…

In di logo with Successful, Hugo Huam n, deputy defender of the right to health, indicated that physiologic serums have been detected with up to 8 times of concentration, after the death of patients who received a dose in treatment.

The Technical Secretariat of the Consumer Protection Commission No. 3 of Indecopi has initiated an administrative sanctioning procedure against Medifarma.